首页> 外文期刊>Archives of Internal Medicine >Risk Factors for Thrombocytopenia in Patients Treated With Prolonged Heparin Therapy
【24h】

Risk Factors for Thrombocytopenia in Patients Treated With Prolonged Heparin Therapy

机译:血小板减少症患者的危险因素接受长期肝素治疗

获取原文
获取原文并翻译 | 示例
           

摘要

We read with great interest the recent study by Oliveira et al. This study reported a high risk of thrombocytopenia in a group of patients receiving heparin therapy, with very few cases caused by heparin-induced thrombocytopenia. These results highlight the high prevalence and incidence rates reported in many intensive care unit-based studies. The study also reported a strikingly important association between thrombocytopenia and risk of death. This observation also corroborates a previously reported association.
机译:我们怀着极大的兴趣阅读了最近的研究奥利维拉et al。一群患者的血小板减少症接受肝素治疗,用很少的情况下肝素诱发的血小板减少症引起的。结果高患病率和亮点在许多重症监护发病率报道单位的研究。非常重要的联系血小板减少症和死亡的风险。观察也证实了先前的协会报告。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号